Back to Oncology
Oncologyv2012Evidence-Based

Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score

Assesses the risk of severe chemotherapy toxicity in older cancer patients (≥70 years). Predicts both hematologic (grade 4) and nonhematologic (grade 3/4) toxicities based on patient characteristics and chemotherapy regimen.

Clinical Input Parameters

U/L
Clinical Assessment
Awaiting Parameters
crash score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CRASH Score = Hematologic Subscore + Nonhematologic Subscore (chemotherapy risk counted only once in combined score)

Clinical Pearls & Practice Notes

  • Designed for patients aged ≥70 years starting chemotherapy
  • Hematologic toxicity defined as grade 4 per CTCAE v3.0
  • Nonhematologic toxicity defined as grade 3/4 per CTCAE v3.0
  • IADL score ranges from 0-29, higher scores indicate better function
  • Chemotherapy risk values are based on specific regimen toxicity profiles

Evidence & Literature Citations

  1. Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012 Jul 1;118(13):3377-86.
  2. Extermann M, Reich RR, Sehovic M. Chemotoxicity recalibration in the common terminology criteria for adverse events version 4.0 in older patients with cancer: Development of a training set. J Geriatr Oncol. 2013 Oct;4(4):353-8.

Score Interpretation Ranges

Tier 10 – 3 pts

Low risk

Tier 24 – 6 pts

Low-intermediate risk

Tier 37 – 9 pts

Intermediate-high risk

Tier 410 – 100 pts

High risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.